Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Centers for Disease Control and Prevention. The History of Malaria: An Ancient Disease. Available at https://stacks.cdc.gov/view/cdc/135582. Last accessed October 13, 2025.
2. World Health Organization. World Malaria Report: 2024. Geneva: WHO Press; 2025. Available at https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024. Last accessed October 13, 2025.
3. Centers for Disease Control and Prevention. Malaria. Available at https://www.cdc.gov/malaria. Last accessed October 13, 2025.
4. Centers for Disease Control and Prevention. Clinical Guidance: Malaria Diagnosis and Treatment in the U.S. Available at https://www.cdc.gov/malaria/hcp/clinical-guidance. Last accessed October 13, 2025.
5. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297(20):2264-2277.
6. Kantele A, Jokiranta S. Plasmodium knowlesi: the fifth species causing human malaria. Duodecim. 2010;126(4):427-434.
7. Wilairatanal P, Krudsood S, Tangpukdee N. Management of Plasmodium knowlesi malaria without PCR confirmation. Southeast Asian J Trop Med Public Health. 2010;41(1):19-21.
8. Lee KS, Cox-Singh J, Singh B. Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malar J. 2009;8:73.
9. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening.Clin Infect Dis. 2008;46(2):165-171.
10. National Institute of Allergy and Infectious Diseases. Malaria. Available at https://www.niaid.nih.gov/diseases-conditions/malaria. Last accessed October 13, 2025.
11. Spadafora C, Awandare GA, Kopydlowski KM, et al. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PloS Pathog. 2010;6(6):e1000968.
12. Figtree M, Lee R, Bain L, et al. Plasmodium knowlesi in human, Indonesian Borneo. Emerg Infect Dis. 2010;16(4):672-674.
13. Zhang M, Fennell C, Ranford-Cartwright L, et al. The Plasmodium eukaryotic initiation factor-2{alpha} kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J Exp Med. 2010;207(7):1465-1474.
14. Sullivan D. Uncertainty in mapping malaria epidemiology: implications for control. Epidemiol Rev. 2010;32(1):175-187.
16. Kappe SH, Vaughan AM, Boddey JA, Cowman AF. That was then but this is now: malaria research in the time of an eradication agenda. Science. 2010;328(5980):862-866.
17. Filler SJ, MacArthur JR, Parise M, et al. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR. 2006;55(RR13):1-9.
18. World Health Organization. Malaria. Available at https://www.who.int/news-room/fact-sheets/detail/malaria. Last accessed October 13, 2025.
19. Medicines for Malaria Venture. First Malaria Medicine for Newborn Babies and Young Infants 2–5 kg Receives Approval. Available at https://www.mmv.org/newsroom/news-resources-search/first-malaria-medicine-newborn-babies-and-young-infants-2-5-kg. Last accessed October 13, 2025.
20. Thwing J, Skarbinski J, Newman RD, et al. Appendix: microscopic procedures for diagnosing malaria. MMWR. 2007;56(SS6):39-40.
21. Maltha J, Gillet P, Bottieau E, Cnops L, van Esbroeck M, Jacobs J. Evaluation of a rapid diagnostic test (CareStartTM Malaria HRP-2/pLDH (Pf/pan) Combo Test) for the diagnosis of malaria in a reference setting. Malar J. 2010;9:171.
22. Centers for Disease Control and Prevention. Malaria Diagnostic Tests. Available at https://www.cdc.gov/malaria/hcp/diagnosis-testing/malaria-diagnostic-tests.html. Last accessed October 13, 2025.
23. Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System Malaria (Plasmodium spp.) 2014 Case Definition. Available at https://ndc.services.cdc.gov/case-definitions/malaria-2014/. Last accessed October 13, 2025.
24. Centers for Disease Control and Prevention. How to Report a Case of Malaria. Available at https://www.cdc.gov/malaria/php/case-reporting. Last accessed October 13, 2025.
25. Lucumi E, Darling C, Jo H, et al. Discovery of potent small molecule inhibitors of multi-drug resistant P. falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob Agents Chemother. 2010;54(9):3597-3604.
27. World Health Organization. Malaria: Rapid Diagnostic Tests. Available at https://www.who.int/teams/global-malaria-programme/case-management/diagnosis/rapid-diagnostic-tests. Last accessed October 13, 2025.
28. Centers for Disease Control and Prevention. Appendix C: How to Acquire IV Artesunate in the United States. Available at https://www.cdc.gov/malaria/hcp/clinical-guidance/iv-artesunate-us.html. Last accessed October 13, 2025.
29. World Health Organization. International Travel and Health: Malaria. Available at https://cdn.who.int/media/docs/default-source/travel-and-health/9789241580472-eng-chapter-7.pdf?sfvrsn=8be7067_13. Last accessed October 13, 2025.
30. Centers for Disease Control and Prevention. Travelers' Health: Yellow Book Homepage. Available at https://www.cdc.gov/yellow-book/index.html. Last accessed October 13, 2025.
31. LexiDrug. Available at https://online.lexi.com. Last accessed October 13, 2025.
32. Centers for Disease Control and Prevention. Preventing Malaria while Traveling. Available at https://www.cdc.gov/malaria/prevention/index.html. Last accessed October 13, 2025.
33. Bell DJ, Lalloo DG. Malaria and travelers. In: Zuckerman JN (ed). Principles and Practice of Travel Medicine. 2nd ed. Oxford: Wiley-Blackwell; 2013: 126-132.
34. Centers for Disease Control and Prevention. Malaria Risk Assessment for Travelers. Available at https://www.cdc.gov/malaria/hcp/risk-assessment. Last accessed October 13, 2025.
35. Brunette GW, Nemhauser JB, Kozarsky PE, et al. (eds). CDC Health Information for International Travel 2020. New York, NY: Oxford University Press; 2020.
36. Centers for Disease Control and Prevention. Counterfeit Medicines. Available at https://wwwnc.cdc.gov/travel/page/counterfeit-medicine. Last accessed October 13, 2025.
37. Centers for Disease Control and Prevention. Strategies for Reducing Malaria's Global Impact. Available at https://www.cdc.gov/malaria/php/public-health-strategy/index.html. Last accessed October 13, 2025.
38. UNICEF. Childhood Diseases. Available at https://www.unicef.org/health/childhood-diseases. Last accessed October 13, 2025.
39. Russell TL, Lwetoijera DW, Maliti D, et al. Impact of promoting longer-lasting insecticide treatment of bed nets upon malaria transmission in a rural Tanzanian setting with pre-existing high coverage of untreated nets. Malar J. 2010;9(1):187.
40. World Health Organization. WHO Publishes Recommendations on Two New Types of Insecticide-Treated Nets. Available at https://www.who.int/news/item/14-03-2023-who-publishes-recommendations-on-two-new-types-of-insecticide-treated-nets. Last accessed October 13, 2025.
41. Smereck J. Malaria in pregnancy: update on emergency management. J Emerg Med. 2011;40(4):393-396.
42. Centers for Disease Control and Prevention. Core Drug-based Malaria Prevention Strategies. Available at https://www.cdc.gov/malaria/php/public-health-strategy/drug-strategies.html. Last accessed October 13, 2025.
43. Kayentao K, Garner P, van Eijk AM, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309(6):594-604.
44. Global Malaria Programme. Indoor Residual Spraying: Use of Indoor Residual Spraying for Scaling Up Global Malaria Control and Elimination. Geneva: World Health Organization; 2006. Available at https://apps.who.int/iris/bitstream/handle/10665/69386/WHO_HTM_MAL_2006.1112_eng.pdf. Last accessed October 13, 2025.
45. Alonso PL, Sacarial J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364(9443):1411-1420.
46. Fauci AS, Touchette NA, Folkers GK. Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerging Infect Dis. 2005;11(4):519-525.
47. Centers for Disease Control and Prevention. Choosing a Drug to Prevent Malaria. Available at https://www.cdc.gov/malaria/hcp/drug-malaria. Last accessed October 13, 2025.
48. Olotu A, Fegan G, Wambua J, et al. Seven-year efficacy of RTS,S/AS01 malarial vaccine among young African children. New Eng J Med. 2016;374:2519-2529.
49. Malaria Vaccine Initiative. Vaccines. Available at https://www.malariavaccine.org/rd/vaccines. Last accessed October 13, 2025.
50. Clemens J, Moorthy V. Implementation of RTS,S/AS01 malaria vaccine: the need for further evidence. New Eng J Med. 2016;374:2596-2597.
51. Malaria Vaccine Initiative. Research and Development. Available at https://www.malariavaccine.org/rd. Last accessed October 13, 2025.
52. Centers for Disease Control and Prevention. DPDx: Malaria. Available at https://www.cdc.gov/dpdx/malaria/index.html. Last accessed October 13, 2025.
53. Centers for Disease Control and Prevention. Where Malaria Occurs. Available at https://www.cdc.gov/malaria/data-research. Last accessed October 13, 2025.
54. Centers for Disease Control and Prevention. CDC and Malaria. Available at https://www.cdc.gov/malaria/cdc-malaria. Last accessed October 13, 2025.
55. World Health Organization. International Travel and Health: Malaria: 2015 update. Geneva: World Health Organization; 2015.
56. Malaria Vaccine Initiative. First-Generation Vaccine: RTS,S. Available at https://www.malariavaccine.org/existing-vaccines/rtss. Last accessed October 13, 2025.
57. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31-45.
58. World Health Organization. World Malaria Report 2018. Available at https://apps.who.int/iris/bitstream/handle/10665/275867/9789241565653-eng.pdf?ua=1. Last accessed October 13, 2025.
59. Centers for Disease Control and Prevention. Congenital malaria—Nassau County, New York, 2004. MMWR. 2005;54(15):383-384.
60. U.S. Food and Drug Administration. CDC and FDA Continue Efforts to Ensure Timely Access to Front-Line Treatments for Severe Malaria. Available at https://www.fda.gov/media/130925/download. Last accessed October 13, 2025.
61. World Health Organization. WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk. Available at https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk. Last accessed October 13, 2025.
62. World Health Organization. Malaria Vaccines (RTS,S and R21). Available at https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine. Last accessed October 13, 2025.
63. Centers for Disease Control and Prevention. Immigrant and Refugee Health: Malaria Guidance. Available at https://www.cdc.gov/immigrant-refugee-health/hcp/overseas-guidance/malaria-guidance.html. Last accessed October 13, 2025.
64. Centers for Disease Control and Prevention. Malaria Vaccines. Available at https://www.cdc.gov/malaria/php/public-health-strategy/malaria-vaccines.html. Last accessed October 13, 2025.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.